Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis. (5th March 2021) - Marcant, P.; Balayé, P.; Merhi, R.; Jendoubi, F.; Nosbaum, A.; Raison‐Peyron, N.; Du‐Thanh, A.; Lasek, A.; Ferrier le Bouedec, M.‐C.; Tetart, F.; Valois, A.; Barbarot, S.; et al.